Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Nilsson

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Plos One|April 4, 2015
Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosisShahin Aeinehband, Rickard P F Lindblom, Faiez Al Nimer, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2008
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanomaC Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, et al.
Plos One|January 12, 2023
Impact of surface coating and systemic anticoagulants on hemostasis and inflammation in a human whole blood modelDoreen Tabea Spiegelburg, Marco Mannes, Anke Schultze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factorGustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Biomacromolecules|April 5, 2021
Pluronic Micelle-Mediated Tissue Factor Silencing Enhances Hemocompatibility, Stemness, Differentiation Potential, and Paracrine Signaling of Mesenchymal Stem CellsVignesh K Rangasami, Ganesh Nawale, Kenta Asawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2019
Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating FactorGustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Frontiers in Immunology|June 20, 2019
C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-ConvertasesFei Zhao, Sara Afonso, Susanne Lindner, et al.
Frontiers in Immunology|January 23, 2026
Nuclear cell-free DNA on the loose: an early warning signal of ischemia-reperfusion injury in kidney transplantationGabriel Strandberg, Rebecca Trattner, Myriam Martin, et al.
Xenotransplantation|October 30, 2008
Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantationMasafumi Goto, Jenny Tjernberg, Denis Dufrane, et al.
Immunological Reviews|October 27, 2016
Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammationKristina N Ekdahl, Yuji Teramura, Osama A Hamad, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Plos One|April 4, 2015
Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosisShahin Aeinehband, Rickard P F Lindblom, Faiez Al Nimer, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2008
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanomaC Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, et al.
Plos One|January 12, 2023
Impact of surface coating and systemic anticoagulants on hemostasis and inflammation in a human whole blood modelDoreen Tabea Spiegelburg, Marco Mannes, Anke Schultze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factorGustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Biomacromolecules|April 5, 2021
Pluronic Micelle-Mediated Tissue Factor Silencing Enhances Hemocompatibility, Stemness, Differentiation Potential, and Paracrine Signaling of Mesenchymal Stem CellsVignesh K Rangasami, Ganesh Nawale, Kenta Asawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2019
Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating FactorGustav J Ullenhag, Jan-Erik Frödin, Mahmood Jeddi-Tehrani, et al.
Frontiers in Immunology|June 20, 2019
C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-ConvertasesFei Zhao, Sara Afonso, Susanne Lindner, et al.
Frontiers in Immunology|January 23, 2026
Nuclear cell-free DNA on the loose: an early warning signal of ischemia-reperfusion injury in kidney transplantationGabriel Strandberg, Rebecca Trattner, Myriam Martin, et al.
Xenotransplantation|October 30, 2008
Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantationMasafumi Goto, Jenny Tjernberg, Denis Dufrane, et al.
Immunological Reviews|October 27, 2016
Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammationKristina N Ekdahl, Yuji Teramura, Osama A Hamad, et al.
Pageof 29